|
Although the implications of many health risks – such
smoking, high cholesterol, and obesity – have long been
understood, the cumulative effect of multiple risks has
not. BioSignia’s flagship technology, Synthesis
AnalysisTM, is a patented statistical method for
summarizing the epidemiological association of the
underlying contributing factors of multifactor diseases
from disparate medical literature into comprehensive
prediction models. In fact, this method is capable of
summarizing virtually the entire body of evidence on
epidemiological factors correlated with the onset of
slowly developing multifactor diseases such as
cardiovascular disease, diabetes, cancer, arthritis, and
other serious chronic illnesses.
Synthesis Analysis is:
-
validated in conjunction with
Duke University and the University of Washington
-
peer-reviewed; white papers
available upon request
-
evergreen; allows for
incorporation of new risk factors faster than
conventional methods
|
